Why Edgewise Therapeutics Shares Are Trading Higher By Over 26%; Here Are 20 Stocks Moving Premarket

Shares of Edgewise Therapeutics, Inc. EWTX rose sharply in today's pre-market trading after the company reported topline results from Phase 2 CANYON trial of Sevasemten in individuals with becker muscular dystrophy.

Edgewise Therapeutics shares jumped 26.5% to $35.00 in the pre-market trading session.

Here are some other stocks moving in pre-market trading.

Gainers

Sidus Space, Inc. SIDU gained 59.4% to $2.28 in pre-market trading after adding 9% on Friday.
SEALSQ Corp LAES gained 48.6% to $2.60 in pre-market trading after falling over 5% on Friday.
U-BX Technology Ltd. UBXG gained 32.3% to $4.40 in pre-market trading.
PureTech Health plc PRTC rose 22.8% to $25.00 in pre-market trading after the company reported positive results from ELEVATE IPF, a Phase 2b randomized, double-blind, active- and placebo-controlled, dose-ranging trial evaluating deupirfenidone (LYT-100) at two dose levels three times a day (TID) over 26 weeks in patients with idiopathic pulmonary fibrosis (IPF).
BTC Digital Ltd. BTCT gained 22.8% to $7.84 in pre-market trading.
Sagimet Biosciences Inc. SGMT climbed 17.2% to $5.15 in pre-market trading after falling over 3% on Friday.
Kratos Defense & Security Solutions, Inc. KTOS gained 14.4% to $30.72 in pre-market trading.
Tonix Pharmaceuticals Holding Corp. TNXP gained 13.8% to $0.2736 in pre-market trading after gaining 5% on Friday.
BitFuFu Inc. FUFU gained 9.1% to $5.64 in pre-market trading following a 9% decline on Friday.

Losers

Akoustis Technologies, Inc. AKTS shares tumbled 39.8% to $0.0410 in pre-market trading after the company filed for Chapter 11 and initiated strategic sale of business amid Qorvo legal dispute.
Roadzen, Inc. RDZN declined 32.6% to $1.20 in pre-market trading after the company priced its $2.5 million public offering of 2 million common shares at $1.25 per share.
SMX (Security Matters) Public Limited Company SMX shares fell 23.9% to $0.2160 in pre-market trading after the company announced the receipt of Nasdaq Listing Delinquency Notice.
Karyopharm Therapeutics Inc KPTI fell 21.6% to $0.55 in pre-market trading.
AtlasClear Holdings, Inc. ATCH dipped 20.5% to $0.1750 in pre-market trading.
Innate Pharma S.A. IPHA shares dipped 19.2% to $2.44 in pre-market trading after jumping 96% on Friday. The company, last week. announced its TELLOMAK Phase 2 trial of Lacutamab demonstrated significant symptom relief and quality of life improvements.
22nd Century Group, Inc. XXII shares fell 17.5% to $0.0404 in pre-market trading after dipping 33% on Friday.
Santech Holdings Limited STEC fell 17.2% to $0.63 in pre-market trading.
Super Micro Computer, Inc. SMCI fell 12.5% to $31.85 in pre-market trading following reports suggesting the company tapped Evercore to raise capital and is considering raising equity and debt.
SPI Energy Co., Ltd. SPI fell 12.1% to $0.34 in today's pre-market trading after jumping over 10% on Friday.